[1]
V. K. Enugula, M. Y. Shaik, V. P. R. M, N. P. B, and S. S. C, “A Comparative Safety and Efficacy Study of Olmesrtan, a Newer Angiotensin-II Type-1 Receptor Blocker in Early Stage Type–2 Diabetes with Hypertension”, JPBR, vol. 4, no. 01, pp. 18–22, Jun. 2016, doi: 10.30904/j.jpbr.2016.2953.